Analysis of acute exacerbation of interstitial lung disease associated with chemotherapy in patients with lung cancer: A feasibility of S-1
Soji Kakiuchi(Tokushima Prefectural Central Hospital), Yasuhiko Nishioka(Tokushima University), Kenji Otsuka(Tokushima University), Yuko Toyoda(Tokushima University), Masahiko Azuma(Tokushima University), Satoshi Sakaguchi(Tokushima University Hospital), Atsuro Saijo(Tokushima University), Toshifumi Tezuka(Tokushima University), Masaki Hanibuchi(Tokushima University), Hiroshi Kawano(Shizuoka Cancer Center), Hisatsugu Goto(Tokushima University), Fumitaka Ogushi(Tokushima University)
Cited by 27
Related Papers
Japanese Society for Cancer of the Colon and Rectum (JSCCR) guidelines 2016 for the treatment of colorectal cancer
|International Journal of Clinical Oncology|2017|2.5k
Hepatocyte Growth Factor Induces Gefitinib Resistance of Lung Adenocarcinoma with Epidermal Growth Factor Receptor–Activating Mutations
|Cancer Research|2008|642
Prediction of sensitivity of advanced non-small cell lung cancers to gefitinib (Iressa, ZD1839)
|Human Molecular Genetics|2004|175